Hyunsu Jung Biography and Net Worth

Chief Executive Officer of Hyperion DeFi

Mr. Jung has served as the Company’s Chief Executive Officer since January 2026, as the Company’s Interim Chief Executive Officer since September 2025, and as the Company’s Chief Investment Officer and a director since June 2025. Prior to joining the Company, from June 2021 to June 2025, Mr. Jung was a Portfolio Manager at DARMA Capital, an $1B+ asset manager registered with the CFTC and NFA. Previously, Mr. Jung was a Consultant at EY-Parthenon from October 2018 to June 2021, where he drove Finance and Digital Transformation for major enterprise M&A deals. Mr. Jung earned his B.A. from Vassar College in 2018.

What is Hyunsu Jung's net worth?: The estimated net worth of Hyunsu Jung is at least $5.27 million as of June 2nd, 2026. Mr. Jung owns 1,385,676 shares of Hyperion DeFi stock worth more than $5,273,883 as of September 23rd. This net worth approximation does not reflect any other investments that Mr. Jung may own. Learn More about Hyunsu Jung's net worth.
How do I contact Hyunsu Jung?: The corporate mailing address for Mr. Jung and other Hyperion DeFi executives is 3090 Nowitzki Way, Suite 300, Dallas, TX, 75219. Hyperion DeFi can also be reached via phone at (833) 393-6684 and via email at [email protected]. Learn More on Hyunsu Jung's contact information.
Has Hyunsu Jung been buying or selling shares of Hyperion DeFi?: Hyunsu Jung has not been actively trading shares of Hyperion DeFi during the last quarter. Most recently, on Tuesday, June 2nd, Hyunsu Jung bought 1,000 shares of Hyperion DeFi stock. The stock was acquired at an average cost of $3.66 per share, with a total value of $3,660.00. Following the completion of the transaction, the insider now directly owns 1,385,676 shares of the company's stock, valued at $5,071,574.16. Learn More on Hyunsu Jung's trading history.
Who are Hyperion DeFi's active insiders?: Hyperion DeFi's insider roster includes Stuart Grant (Major Shareholder), Tsontcho Ianchulev (CEO), Hyunsu Jung (Chief Executive Officer), David Knox (CFO), Kenneth Lee, Jr. (Director), Charles Mather, IV (Director), Michael Rowe (COO), Ellen Strahlman (Director), and Happy Walters (Director). Learn More on Hyperion DeFi's active insiders.
Are insiders buying or selling shares of Hyperion DeFi?: In the last twelve months, Hyperion DeFi insiders bought shares 11 times. They purchased a total of 197,204 shares worth more than $641,026.94. The most recent insider tranaction occured on June, 2nd when insider Hyunsu Jung bought 1,000 shares worth more than $3,660.00. Insiders at Hyperion DeFi own 7.5% of the company. Learn More about insider trades at Hyperion DeFi.
Information on this page was last updated on 6/2/2026.

Hyunsu Jung Insider Trading History at Hyperion DeFi

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/2/2026	Buy	1,000	$3.66	$3,660.00	1,385,676
6/1/2026	Buy	7,000	$3.70	$25,900.00	1,384,676

Hyunsu Jung Buying and Selling Activity at Hyperion DeFi

Hyperion DeFi Company Overview

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

Today's Range

Now: $3.85

$3.71

$3.89

50 Day Range

MA: $3.05

$2.34

$3.99

2 Week Range

Now: $3.85

$2.34

$11.89

Volume

309,089 shs

Average Volume

468,073 shs

Market Capitalization

$59.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.53